SBTi Registry
Explore 1 matching companies with public, verified Science Based Targets commitments.
Data sourced from the Science Based Targets initiative (SBTi).
Show
20
per page| Sector | Region | Near-Term Status | Size | ||||
|---|---|---|---|---|---|---|---|
| POLYPEPTIDE GROUP AG | Pharmaceuticals, Biotechnology and Life Sciences | Europe | Targets set | Medium | 1 | Sep 18, 2025 | |
Near-Term Status Targets set Near-Term Classification 1.5°C Near-Term Target Year 2033 Long-Term Status - Net-Zero Status - Net-Zero Year - Sector Pharmaceuticals, Biotechnology and Life Sciences Region Europe Organization Type Corporate Location Switzerland Company Size Medium Target Statement Near-Term Targets: POLYPEPTIDE GROUP AG commits to reduce absolute scope 1 and 2 GHG emissions 42.0% by 2030 from a 2023 base year. POLYPEPTIDE GROUP AG also commits to increase active annual sourcing of renewable electricity from 54.0% in 2023 to 100% by 2029 and to continue act… Stakeholders Global Head of Sustainability and Corporate Compliance | |||||||
Show
20
per pageTurn Commitments Into Impact
Thousands of companies have set public Scope 3 emissions-reduction targetsthrough SBTi, but few have the tools to deliver on them. Carbon3 gives you the infrastructure to plan, track, and execute the supply-chain decarbonization work behind your commitment, turning a public pledge into measurable progress. See how it works.